Company intelligence / Profile preview

Sigyn Therapeutics

San Diego, California, United Statessigyntherapeutics.com ↗

Ownership: Public · SIGY
Employees: ~5
Development stage: Preclinical

Overview

Sigyn Therapy has demonstrated in vitro the ability to remove a broad range of pathogen and inflammatory targets from human blood plasma. Animal studies have been completed at the University of Michigan. First-in-human feasibility studies are planned for end-stage renal disease patients with endotoxemia and inflammation. The ImmunePrep platform is designed to enhance immunotherapeutic antibodies; ChemoPrep aims to improve chemotherapy delivery; ChemoPure reduces off-target chemotherapy toxicity.

Therapeutic areas: OncologyNephrologyInfectious Diseases
Modalities: Device (extracorporeal blood purification)Platform technology (for antibody and chemotherapy enhancement)
Industry: Therapeutic Medical Devices

Drug pipeline

4 assets

Sigyn Therapy

Pre-clinical

Indications: Infectious diseases, Sepsis, Endotoxemia

3 more assets in the full pipeline.

Request access →

Partnerships

None disclosed as major pharmaceutical or biotech partnerships as of June 2025.

Financials

Market cap: $46.6K
Total revenue: $0
Enterprise value: $3.2M

Beyond the preview

Go deeper on Sigyn Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sigyn Therapeutics.

Explore the full profile